---
title: "MapLight Therapeutics Announces $150 Million Private Placement Financing"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295807484.md"
description: "MapLight Therapeutics (MPLT) announced a $150 million private placement financing on August 13, 2026. The clinical-stage biopharmaceutical company partnered with institutional and accredited investors via a securities purchase agreement to raise capital before fees and expenses. This round includes both new and existing institutional supporters."
datetime: "2026-08-13T13:11:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295807484.md)
  - [en](https://longbridge.com/en/news/295807484.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295807484.md)
generator: "portal-rs"
---

# MapLight Therapeutics Announces $150 Million Private Placement Financing

In a recent announcement on August 13, 2026, MapLight Therapeutics, Inc., listed on Nasdaq as MPLT, has disclosed a new initiative. The clinical-stage biopharmaceutical company, with headquarters in both San Francisco and Boston, aims to enhance the quality of life for individuals dealing with severe central nervous system disorders. Through a securities purchase agreement, they have partnered with institutional and accredited investors for a private placement financing (the “PIPE”), resulting in a substantial gross profit of about $150 million. This total amount is before any deductions for placement agent fees and anticipated offering expenses. The financing round is notably backed by a combination of fresh investors as well as existing institutional supporters.

### Related Stocks

- [MPLT.US](https://longbridge.com/en/quote/MPLT.US.md)

## Related News & Research

- [Agomab Therapeutics to join Citi Biopharma Back to School investor conference](https://longbridge.com/en/news/297952645.md)
- [Seaport Therapeutics participates in Citi Biopharma Back to School conference fireside chat](https://longbridge.com/en/news/297505123.md)
- [BlossomHill Therapeutics (NASDAQ:BLSM) Now Covered by Analysts at JPMorgan Chase & Co.](https://longbridge.com/en/news/297657599.md)
- [Dianthus Therapeutics CEO to join Citi Biopharma Back to School fireside chat](https://longbridge.com/en/news/297649677.md)
- [Spyre Therapeutics to present at Citi BioPharma Back to School conference](https://longbridge.com/en/news/297953094.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**